Alpine Global Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,765
| Closed | -$661K | – | 621 |
|
|
2021
Q4 | $661K | Buy |
+7,765
| New | +$661K | 0.1% | 270 |
|
|
2020
Q1 | – | Sell |
-3,236
| Closed | -$348K | – | 368 |
|
|
2019
Q4 | $348K | Buy |
+3,236
| New | +$348K | 0.07% | 239 |
|
|
2018
Q4 | – | Sell |
-2,619
| Closed | -$322K | – | 250 |
|
|
2018
Q3 | $322K | Buy |
+2,619
| New | +$322K | 0.06% | 61 |
|
|
2014
Q4 | – | Sell |
-35,000
| Closed | -$548K | – | 609 |
|
|
2014
Q3 | $548K | Sell |
35,000
-65,000
| -65% | -$1.02M | 0.41% | 60 |
|
|
2014
Q2 | $1.48M | Buy |
100,000
+77,105
| +337% | +$1.14M | 0.43% | 37 |
|
|
2014
Q1 | $369K | Buy |
+22,895
| New | +$369K | 0.32% | 63 |
|